HematologyImmunologyInfectious DiseasesOncologyBiotechnologyHealth CareScience and Engineering
Description
PharmaEssentia Corporation, a pharmaceutical company, primarily focusing on the research and development of innovative medicine solutions. The company specializes in developing therapies for various diseases, with a significant emphasis on advancing…
Analysis
Middle-of-the-road
PharmaEssentia Corporation is a middle-of-the-road business: neither the economics nor the price stand out from the peer group. One caution: reported profits have recently run ahead of actual cash, which we track closely.
The price is expensive. You pay 89.6× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone.
The trajectory is moderate and the balance sheet is sturdy. The company scores 20/20 on our value-creation score: strong value creator. Analyst sentiment is cautious.
What to watch: Some accounting patterns deserve a closer look. Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Mar 202696
91
2026
All-time high
96
Mar 2026
All-time low
91
Jun 2026
Average rank
94
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
8
—
—
—
Price/Earnings
9
—
—
—
Price/Book
7
—
—
—
Dividend Yield
83
—
—
—
Value (overall)
15
—
—
—
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.